Published in Oncologist on February 26, 2013
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol (2015) 4.24
Drugs, cancer and end-of-life care: a case study of pharmaceuticalization? Soc Sci Med (2014) 2.03
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol (2014) 1.70
Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. J Clin Oncol (2016) 1.66
Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer (2013) 1.36
Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) (2013) 1.33
Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist (2014) 1.13
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014. J Natl Cancer Inst (2016) 1.10
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol (2014) 1.06
Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Med Care (2013) 1.04
Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract (2014) 1.04
Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology. J Clin Oncol (2015) 1.03
Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist (2014) 1.02
Recognizing the Financial Burden of Cancer Patients in Clinical Trials. Oncologist (2015) 0.99
Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. J Clin Oncol (2015) 0.99
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol (2015) 0.98
Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study. JAMA Oncol (2016) 0.94
ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. J Oncol Pract (2016) 0.90
A universal decision support system. Addressing the decision-making needs of patients, families, and clinicians in the setting of critical illness. Am J Respir Crit Care Med (2014) 0.89
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients. Oncologist (2015) 0.88
Value: a framework for radiation oncology. J Clin Oncol (2014) 0.88
The imperative to address the cost of oncology care. J Natl Cancer Inst (2013) 0.88
Setting the vision: applied patient-reported outcomes and smart, connected digital healthcare systems to improve patient-centered outcomes prediction in critical illness. Curr Opin Crit Care (2014) 0.86
Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis. PLoS One (2016) 0.85
Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. J Clin Oncol (2016) 0.85
Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. Oncologist (2016) 0.85
It's time to have 'the talk': cost communication and patient-centered care. Oncology (Williston Park) (2014) 0.85
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer. JAMA Oncol (2016) 0.85
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Res Treat (2015) 0.84
The Affordable Care Act and Expanded Insurance Eligibility Among Nonelderly Adult Cancer Survivors. J Natl Cancer Inst (2015) 0.84
Financial hardship and the intensity of medical care received near death. Psychooncology (2014) 0.84
Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer? Cancer (2015) 0.83
Oncologists' experiences with drug shortages. J Oncol Pract (2014) 0.83
Adaptation of Cost Analysis Studies in Practice Guidelines. Medicine (Baltimore) (2015) 0.83
A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care (2014) 0.82
Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors. J Clin Oncol (2015) 0.82
Patient Attitudes Regarding the Cost of Illness in Cancer Care. Oncologist (2015) 0.80
What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits. Med Decis Making (2016) 0.80
Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates. BMC Health Serv Res (2016) 0.80
Geography and the burden of care in pediatric cancers. Pediatr Blood Cancer (2014) 0.80
Predictors of financial difficulties and work modifications among cancer survivors in the United States. J Cancer Surviv (2015) 0.79
Inpatient care burden due to cancers in Anhui, China: a cross-sectional household survey. BMC Public Health (2016) 0.79
The impact of health insurance on cancer care in disadvantaged communities. Cancer (2016) 0.78
Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis. J Palliat Med (2015) 0.78
Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer (2015) 0.78
Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act. J Clin Oncol (2017) 0.77
Financial Distress in Cancer Patients. J Med Person (2013) 0.77
The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive? Oncologist (2013) 0.76
Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period. Int J Circumpolar Health (2015) 0.75
Patient-reported outcome measures of the impact of cancer on patients' everyday lives: a systematic review. J Cancer Surviv (2016) 0.75
Care of the Elderly Patient on Oral Oncolytics for Advanced Disease. Curr Geriatr Rep (2016) 0.75
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity. Cancer (2016) 0.75
A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients? Oncologist (2016) 0.75
There is a mismatch between the medicare benefit package and the preferences of patients with cancer and their caregivers. J Clin Oncol (2014) 0.75
Oral cancer therapy: policy implications for the uninsured and underinsured populations. J Adv Pract Oncol (2013) 0.75
The cost of cancer: a retrospective analysis of the financial impact of cancer on young adults. Cancer Med (2016) 0.75
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer. J Oncol Pract (2016) 0.75
Variation in primary site resection practices for advanced colon cancer: a study using the National Cancer Data Base. Am J Surg (2016) 0.75
A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment. Cancer (2016) 0.75
Recent relocation and decreased survival following a cancer diagnosis. Prev Med (2016) 0.75
Bringing a genomic perspective to the safety of drug treatment in oncology. F1000Res (2017) 0.75
Importance of cost-effectiveness and value in cancer care and healthcare policy. J Surg Oncol (2016) 0.75
Insurance Status and Hospital Payer Mix Are Linked With Variation in Metastatic Site Resection in Patients With Advanced Colorectal Cancers. Dis Colon Rectum (2016) 0.75
Communication with Physicians about Health Care Costs: Survey of an Insured Population. Perm J (2017) 0.75
Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology. Adv Ther (2016) 0.75
Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status. Cancer Epidemiol (2016) 0.75
Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions. Oncologist (2017) 0.75
Psychosocial, clinical and demographic features related to worry in patients with melanoma. Melanoma Res (2016) 0.75
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia. J Cancer Res Clin Oncol (2017) 0.75
Quality of Life and Its Determinants in Adult Cancer Patients Undergoing Chemotherapy Treatment in Pakistan. Asia Pac J Oncol Nurs (2017) 0.75
With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern. Dis Colon Rectum (2018) 0.75
Sociodemographic disparities in survival for adolescents and young adults with cancer differ by health insurance status. Cancer Causes Control (2017) 0.75
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA (2007) 6.51
Patient-physician communication about out-of-pocket costs. JAMA (2003) 4.47
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol (2012) 2.72
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol (2004) 2.30
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00
Out-of-pocket health-care expenditures among older Americans with cancer. Value Health (2004) 1.86
Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent. Health Aff (Millwood) (2011) 1.82
National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol (2011) 1.81
Impact of the cost of cancer treatment: an internet-based survey. J Oncol Pract (2010) 1.73
Without the individual mandate, the Affordable Care Act would still cover 23 million; premiums would rise less than predicted. Health Aff (Millwood) (2011) 1.68
Financial stress and strain associated with terminal cancer--a review of the evidence. Palliat Med (2007) 1.67
Cost of cancer care: the patient perspective. J Clin Oncol (2007) 1.55
An examination of cancer patients' monthly 'out-of-pocket' costs in Ontario, Canada. Eur J Cancer Care (Engl) (2007) 1.53
Increasing response rates for mailed surveys of Medicaid clients and other low-income populations. Am J Epidemiol (1999) 1.48
A copay foundation assistance support program for patients receiving intravenous cancer therapy. J Oncol Pract (2011) 1.17
Understanding patient perspectives on communication about the cost of cancer care: a review of the literature. J Oncol Pract (2010) 1.07
Impact of health care reform legislation on uninsured and medicaid-insured cancer patients. Cancer J (2010) 1.06
Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. J Clin Oncol (2011) 1.03
What works in market-oriented health policy? N Engl J Med (2009) 0.99
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Primary care physicians who treat blacks and whites. N Engl J Med (2004) 12.23
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol (2012) 7.54
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
Care patterns in Medicare and their implications for pay for performance. N Engl J Med (2007) 6.74
The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst (2007) 6.12
Using navigators to improve care of underserved patients: current practices and approaches. Cancer (2005) 5.56
Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA (2004) 5.43
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol (2010) 5.21
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med (2013) 4.27
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
How to build and interpret a nomogram for cancer prognosis. J Clin Oncol (2008) 4.24
Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med (2010) 4.11
Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA (2009) 4.04
The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med (2003) 4.01
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol (2008) 3.93
Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol (2006) 3.83
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ (2014) 3.75
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol (2006) 3.75
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol (2007) 3.60
When you look matters: the effect of assessment schedule on progression-free survival. J Natl Cancer Inst (2007) 3.60
Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med (2009) 3.59
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care (2002) 3.57
Delivery of preventive services to older adults by primary care physicians. JAMA (2005) 3.53
Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol (2011) 3.53
Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol (2005) 3.29
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol (2007) 3.07
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Psychological interventions for arthritis pain management in adults: a meta-analysis. Health Psychol (2007) 2.92
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. J Infect Dis (2011) 2.60
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol (2012) 2.59
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study. J Clin Oncol (2011) 2.47
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol (2006) 2.32
Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer. J Clin Oncol (2012) 2.15
Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med (2013) 2.10
Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol (2007) 2.04
Rapidity and modality of imaging for acute low back pain in elderly patients. Arch Intern Med (2009) 2.01
Promoting patient centred palliative care through case conferencing. Aust Fam Physician (2007) 1.98
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97
Use of information resources by patients with cancer and their companions. Cancer (2004) 1.93
Full disclosure--out-of-pocket costs as side effects. N Engl J Med (2013) 1.90
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc (2007) 1.89
Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol (2005) 1.87
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer (2005) 1.86
Cancer screening among patients with advanced cancer. JAMA (2010) 1.82
Development of a subject search filter to find information relevant to palliative care in the general medical literature. J Med Libr Assoc (2006) 1.82
Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial. Ann Intern Med (2011) 1.78
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care (2009) 1.76
Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol (2011) 1.75
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
Use of tablet personal computers for sensitive patient-reported information. J Support Oncol (2009) 1.73
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol (2011) 1.71
Prescribing in palliative care as death approaches. J Am Geriatr Soc (2007) 1.68
Attribution of deaths following cancer treatment. J Natl Cancer Inst (2002) 1.63
A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol (2014) 1.62
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care (2009) 1.62
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. J Natl Cancer Inst (2014) 1.61
Defining best supportive care. J Clin Oncol (2008) 1.60
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59
Managing comorbidities in patients at the end of life. BMJ (2004) 1.59
Handheld computers for data entry: high tech has its problems too. Trials (2007) 1.57
Number of children associated with obesity in middle-aged women and men: results from the health and retirement study. J Womens Health (Larchmt) (2004) 1.56
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55
Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med (2012) 1.54
Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum (2008) 1.53
Analyzing phase III studies in hospice/palliative care. a solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis. J Pain Symptom Manage (2012) 1.53
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer (2008) 1.53
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc. Clin Infect Dis (2011) 1.53
Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist (2013) 1.52
Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52
A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr (2005) 1.51
Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol (2014) 1.51
Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist (2011) 1.50
Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ann Fam Med (2004) 1.47
Reliability of adverse symptom event reporting by clinicians. Qual Life Res (2011) 1.45
Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst (2013) 1.45
Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Stat Med (2007) 1.44
Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage (2011) 1.42